author-photo

Arlene Chan

The Breast Cancer Research Foundation
Curtin University

169

Papers

11516

Citations

Citation Trend

Filter By

Papers (119) Sort By

Journal Conference Others

Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (3)
BreastSurgANZ members recommendations for adjuvant systemic treatment and patient compliance in Australian breast cancer patients.

2021 Anz Journal of Surgery
Show All
- Source
- Cite
- Save
Citations (0)
Safety and impact of dose reductions on efficacy in the randomised MONALEESA-2, -3 and -7 trials in hormone receptor-positive, HER2-negative advanced breast cancer.

2021 British Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Incorporation of eribulin in the systemic treatment of metastatic breast cancer patients in Australia.

2021 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Bone Health Outcomes from the International, Multicenter, Randomized, Phase 3, Placebo-Controlled D-CARE Study Assessing Adjuvant Denosumab in Early Breast Cancer.

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Continued efficacy of neratinib in patients with HER2-positive (HER2+) early-stage breast cancer: final overall survival (OS) analysis from the randomized phase 3 ExteNET trial

2021 The Breast
Show All
- Source
- Cite
- Save
Citations (0)
Abstract GS4-01: Results from CONTESSA: A phase 3 study of tesetaxel plus a reduced dose of capecitabine versus capecitabine alone in patients with HER2-, hormone receptor + (HR+) metastatic breast cancer (MBC) who have previously received a taxane

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (1)
Abstract PD3-03: Continued efficacy of neratinib in patients with HER2-positive early-stage breast cancer: Final overall survival analysis from the randomized phase 3 ExteNET trial

2021 Cancer Research
Show All
- Source
- Cite
- Save
Citations (0)
Drug induced vitiligo-like depigmentation from a CDK 4/6 inhibitor

2021 Asia-pacific Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
A Randomized Phase II Study of Anti-CSF-1 Monoclonal Antibody Lacnotuzumab (MCS110) Combined with Gemcitabine and Carboplatin in Advanced Triple Negative Breast Cancer

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (4)